Your prediction
Takeda Pharmaceutical Co Ltd Stock
Takeda Pharmaceutical Co Ltd shows a slight decrease today, losing -€0.170 (-0.680%) compared to yesterday.
Our community identified positive and negative aspects for Takeda Pharmaceutical Co Ltd stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Takeda Pharmaceutical Co Ltd stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Takeda Pharmaceutical Co Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Takeda Pharmaceutical Co Ltd vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | -0.680% | 1.016% | -1.114% | -18.170% | -4.200% | -11.813% | -22.313% |
Santen Pharmaceutical Corp Ltd. | -3.080% | 3.846% | 8.000% | 16.667% | 6.180% | -10.849% | -27.852% |
Dainippon Sumitomo Pharma | -1.650% | 12.264% | -2.459% | -54.667% | -18.493% | -83.699% | -87.457% |
Chugai Pharmaceutical Co Ltd | 0.210% | -3.855% | -7.752% | 15.645% | -15.148% | -7.663% | - |
Comments
News
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement